ScreenerHero
SBRASabra Health Care REIT, Inc.
NAS · US · Real Estate · REIT - Healthcare Facilities · sabrahealth.com
20.46USD-0.39%Mkt Cap: 5.25B $P/E: 79.00

Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the Unite…

Industry Peers

REIT - Healthcare Facilities
Screen all
WELL
Welltower Inc.
$169.86BUSDP/E 105.2
VTR
Ventas, Inc.
$47.11BUSDP/E 167.0
OHI
Omega Healthcare Investors, Inc.
$14.80BUSDP/E 16.7
DOC
Healthpeak Properties, Inc.
$14.72BUSDP/E 59.3
CTRE
CareTrust REIT, Inc.
$9.41BUSDP/E 24.9
HR
Healthcare Realty Trust Incorporated
$6.78BUSD
AED
Aedifica SA
$6.17BUSDP/E 5.9
CSH-UN
Chartwell Retirement Residences
$5.06BUSDP/E 1054.0
NHI
National Health Investors, Inc.
$3.64BUSDP/E 21.4
PHP
Primary Health Properties PLC
$3.17BUSDP/E 15.9
MPT
Medical Properties Trust Inc. common stock
$2.48BUSD
LTC
LTC Properties, Inc.
$2.17BUSDP/E 14.4
DHC
Diversified Healthcare Trust
$1.96BUSD
SILA
Sila Realty Trust Inc. Common Stock
$1.68BUSDP/E 44.6
STRW
Strawberry Fields REIT Inc. Common Stock
$769.23MUSDP/E 20.9
NHP
National Healthcare Properties Inc. Class A Common Stock
$747.36MUSD
CPINV
Care Property Invest
$563.33MUSDP/E 8.1
UHT
Universal Health Realty Income Trust
$571.24MUSDP/E 29.6
XRN
Chiron Real Estate Inc. Common Stock
$533.88MUSDP/E 9.9
CHCT
Community Healthcare Trust Incorporated
$422.58MUSDP/E 22.1

Key Statistics

Company
Market Cap5.25B $
Enterprise Value7.63B $
Revenue (TTM)863.77M $
Gross Profit503.53M $
Net Income (TTM)155.61M $
Revenue/Share3.477 USD
Last Price20.46 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees58
CountryUS
SectorReal Estate
IndustryREIT - Healthcare Facilities
ISINUS78573L1061
Valuation
P/E (Trailing)79.00
P/E (Forward)26.43
PEG5.28
EV/EBITDA20.68
EV/Revenue8.84
P/S6.07
P/B1.91
EPS (TTM)0.26
EPS (Forward)0.78
52W Range
17.1759% of range22.77
52W High22.77 USD
52W Low17.17 USD
Profitability
Gross Margin65.00%
Oper. Margin-12.53%
EBITDA Margin42.74%
Profit Margin20.09%
ROE5.51%
ROA2.83%
Growth
Revenue Growth25.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF348.61M $
CapEx (TTM)—
FCF Margin17.96%
FCF Yield2.96%
Net Debt2.39B $
Net Debt/EBITDA6.47
Balance Sheet
Debt/Equity0.90
Current Ratio3.57
Quick Ratio3.25
Book Value/Sh10.77 USD
Cash/Share0.9640 USD
Dividends
Fwd Div Rate1.200 USD
Trail. Div Rate1.200 USD
Div. Yield5.84%
5Y Avg Yield7.93%
Payout Ratio461.54%
Ex-Div DateAug 14, 2026
Pay DateAug 31, 2026
Splits
Last Split1:3
Split DateNov 16, 2010
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)22.57 USD
Upside (mean)+10.3%
Target Range19.00 USD – 25.00 USD
$19.00+10.3% to mean$25.00
# Analysts14
Ownership
Shares Out.255.46M
Float251.21M
Insiders1.40%
Institutions105.42%
Short Interest
Short Ratio8.1d
Short % Float13.17%
Short % Out.9.60%
Shares Short24.54M
Short (prev mo.)26.38M
Technical
SMA 5020.13 (+1.6%)
SMA 20019.74 (+3.6%)
Beta0.64
S&P 52W Chg18.16%
Avg Vol (30d)2.77M
Avg Vol (10d)2.43M
Technical Indicators
RSI (14)49.5
MACD-0.0275
MACD Signal0.1155
MACD Hist.-0.1430
BB Upper22.73 USD
BB Middle21.09 USD
BB Lower19.46 USD
BB Width15.50%
ATR (14)0.5379 USD
Vol Ratio (20d)0.52x